Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 5.430E-13 | 1.182E-08 | CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.789E-11 | 9.739E-08 | CYP2A6, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 2.193E-08 | 3.979E-05 | CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 7.853E-08 | 1.069E-04 | CYP2A6, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.322E-07 | 1.589E-04 | CYP2A6, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 2.351E-07 | 2.226E-04 | CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 7.235E-07 | 6.059E-04 | CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0044281; small molecule metabolic process | 4.119E-06 | 2.718E-03 | CA12, CA9, CYP2A6, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009804; coumarin metabolic process | 5.059E-06 | 3.060E-03 | CYP2A6, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.083E-05 | 5.896E-03 | CYP2C19, CYP2C9 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.498E-03 | 1.612E-02 | CYP2A6 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 4.187E-04 | 3.303E-03 | CYP2C9; CYP2C19 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.267E-07 | 5.798E-06 | CYP2C9; CYP3A4; CYP2C19 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 3.868E-06 | 5.493E-05 | CYP2C9; CYP2A6; CYP3A4 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.048E-05 | 3.091E-04 | CA12; CA9 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.373E-08 | 1.197E-06 | CYP2C9; CYP2A6; CYP2D6; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.048E-10 | 7.444E-09 | CYP2C9; CYP2A6; CYP2D6; CYP3A4; CYP2C19 |
hsa00983 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.302E-04 | 2.043E-03 | CYP2A6; CYP3A4 |
hsa01100 | Metabolic pathways_Homo sapiens_hsa01100 | 2.276E-03 | 1.612E-02 | CYP2C9; CYP2A6; CYP2C19; CYP3A4 |
hsa04024 | cAMP signaling pathway_Homo sapiens_hsa04024 | 4.206E-03 | 2.489E-02 | NFKB1; TSHR |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6 |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9 |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
C00-D49: Neoplasms | Breast cancer | C50 | CA9 |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; NFKB1; ACHE |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9 |